Table 3 Drugs with constant (patient-independent) effects
From: The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Predictor | % change in absorbance per drug dose (SEM) | p-value |
|---|---|---|
Infliximab | -20% (9%) | 0.025 |
Leflunomide | -21% (9%) | 0.022 |
Etoricoxib × Dexamethasone | -14% (7%) | 0.041 |